Steven Cohen’s Beta Bionics BBNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$18.4M Sell
967,144
-1,287,539
-57% -$23.1M 0.02% 960
2026
Q2
$35.3M Sell
2,254,683
-270,357
-11% -$3.22M 0.04% 588
2026
Q1
$25.3M Buy
2,525,040
+1,537,689
+156% +$22.7M 0.03% 684
2025
Q4
$30.1M Buy
+987,351
New +$26.4M 0.03% 654
2025
Q2
– Sell
-364,329
Closed -$4.46M – 2676
2025
Q1
$4.46M Buy
+364,329
New +$6.79M 0.01% 963

Other funds holding BBNX

Steven Cohen's BBNX Position: Q3 2026 in Review

Steven Cohen reduced its Beta Bionics (BBNX) stake by 57% in Q3 2026, selling an estimated $23.1M and leaving 967,144 shares worth $18.4M. The position accounts for 0.02% of the portfolio, ranked #960.

Steven Cohen first reported a position in BBNX in Q1 2025 and has held it in 5 quarters since. The position peaked at $35.3M in Q2 2026. 151 funds tracked by Wall St. Rank hold BBNX as of Q3 2026.

  • Steven Cohen held 967,144 shares of Beta Bionics worth $18.4M as of Q3 2026.
  • Steven Cohen sold 1,287,539 Beta Bionics shares in Q3 2026, an estimated $23.1M.
  • Beta Bionics made up 0.02% of Steven Cohen's portfolio in Q3 2026, its #960 holding.
  • Steven Cohen first reported a position in Beta Bionics in Q1 2025 and has held it in 5 quarters since.
  • Steven Cohen's Beta Bionics position peaked at $35.3M in Q2 2026.
  • 151 funds tracked by Wall St. Rank held Beta Bionics as of Q3 2026.

Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.